In the January 31 issue of IBO, the first Executive Briefing on page 2 discussed the divestment of four businesses required by the EU for approval of Agilent’s purchase of Varian. IBO incorrectly identified that Varian’s micro GC business would be sold. It is Agilent’s micro GC business that will be divested.
The inherent characteristics of NIR spectroscopy make it a logical choice for process analysis applications. As with other spectroscopy techniques, NIR offers instantaneous noncontact analysis of liquids and powders, and is able to perform analyses through glass. Relative to mid-infrared spectroscopy, NIR can penetrate much further into a sample, which makes it more amenable for […]
The importance of a company’s web site for sales and marketing is common knowledge. For life science research consumables, online sales and marketing are especially important. Rapid advances in the life science field, as well as the specialization and customization of reagents, kits and consumables used for life science research make purchasing online a natural […]
Foster City, CA and Ontario, Canada 2/1/10; Carlsbad, CA 2/1/10; Ontario, Canada 2/1/10; Washington, DC 2/1/10—Danaher and MDS have announced the completion of Danaher’s acquisition of MDS Analytical Technologies for $650 million in cash (see IBO 9/15/09), which includes the acquisition of MDS Sciex and Life Technologies’ MS joint venture. The new company for the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
